4
Changes in Ownership
PMV Pharmaceuticals, Inc. Filed Acc 0001415889-24-024627
Options or other derivatives
- Chief Development Officer acquired 215,774 shares (grant or award)
- Chief Development Officer returned 215,774 shares (to the company)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Jalota Deepika Chief Development Officer | 2024-08-13 | Returned to the company · Employee Stock Option (right to buy) | −22,674 | 0 | D | ||
| Jalota Deepika Chief Development Officer | 2024-08-13 | Returned to the company · Employee Stock Option (right to buy) | −68,100 | 0 | D | ||
| Jalota Deepika Chief Development Officer | 2024-08-13 | Grant or award · Employee Stock Option (right to buy) | +90,774 | 90,774 | D | ||
| Jalota Deepika Chief Development Officer | 2024-08-13 | Returned to the company · Employee Stock Option (right to buy) | −125,000 | 0 | D | ||
| Jalota Deepika Chief Development Officer | 2024-08-13 | Grant or award · Employee Stock Option (right to buy) | +125,000 | 125,000 | D | ||
Loading xslF345X05/form4-10032024_081022.xml…